Position in KROS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$765,723
-$203,279 QoQ
Shares Held
71,563
-18.5% QoQ
Ownership
0.361%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 131 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. KROS ranks #164 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in KROS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $765,723 | 71,563 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $969,002 | 87,772 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,780,032 | 87,428 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,186,166 | 74,979 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $579,321 | 43,395 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $338,979 | 33,266 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $199,709 | 12,616 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $706,303 | 12,163 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $542,230 | 11,865 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,870,813 | 88,683 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $396,804 | 9,980 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $527,645 | 16,551 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $447,684 | 11,142 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $445,872 | 10,442 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $375,851 | 7,827 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $303,065 | 8,056 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $379,571 | 6,980 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $405,883 | 6,937 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $301,722 | 7,627 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,206,653 | 75,504 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $11,782,084 | 191,423 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $13,382,777 | 189,719 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $7,254,321 | 188,082 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $11,321,455 | 301,825 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||